Hardin Capital Partners’s Colgate-Palmolive CL Stock Holding History

Hardin Capital Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$371K	Buy	4,052 +100	+3%	+$8.75K	0.17%	83
2026 Q1	$337K	Hold	3,952	–	–	0.16%	90
2025 Q4	$312K	Buy	3,952 +50	+1%	+$3.92K	0.15%	97
2025 Q3	$312K	Hold	3,902	–	–	0.17%	89
2025 Q2	$359K	Hold	3,902	–	–	0.21%	81
2025 Q1	$366K	Buy	3,902 +50	+1%	+$4.48K	0.22%	75
2024 Q4	$350K	Hold	3,852	–	–	0.21%	75
2024 Q3	$387K	Hold	3,852	–	–	0.22%	68
2024 Q2	$374K	Buy	+3,852	New	+$355K	0.24%	63

Other funds holding CL

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hardin Capital Partners's CL Position: Q2 2026 in Review

Hardin Capital Partners increased its Colgate-Palmolive (CL) stake by 2.5% in Q2 2026, buying an estimated $8.75K and bringing the position to 4,052 shares worth $371K. The position accounts for 0.17% of the portfolio, ranked #83.

Hardin Capital Partners first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $387K in Q3 2024. 1,167 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Hardin Capital Partners held 4,052 shares of Colgate-Palmolive worth $371K as of Q2 2026.
Hardin Capital Partners bought 100 Colgate-Palmolive shares in Q2 2026, an estimated $8.75K.
Colgate-Palmolive made up 0.17% of Hardin Capital Partners's portfolio in Q2 2026, its #83 holding.
Hardin Capital Partners first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
Hardin Capital Partners's Colgate-Palmolive position peaked at $387K in Q3 2024.
1,167 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hardin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.